Metabolic Solutions Development Co
Latest round
- Series B
Last raised
- Jan 2008
Total raised
- Undisclosed
Investors
- 1
About Metabolic Solutions Development Co
Based in Michigan, US, and founded in 2006 by Chief Executive Officer Stephen Benoit, Metabolic Solutions Development Company LLC operates as a healthcare company providing insulin sensitizers, MSDC-0160 and MSDC-0602, mTOT modulators that lower glucose without the same degree of unwanted side effects such as fluid retention, weight gain, heart failure, edema, and bone loss. Metabolic Solutions Development Company LLC specializes in drug discovery and development focused on creating therapeutics for metabolic diseases linked to age-related mitochondrial dysfunction such as insulin resistance and type 2 diabetes. The company’s flagship products are its mTOT Modulators, including MSDC-0160 and MSDC-0602. These compounds are designed to improve insulin sensitivity by targeting the mitochondrial Target of Thiazolidinediones (mTOT) complex. It focuses on treating neurodegenerative diseases such as Alzheimer's and Parkinson's.
Who invested in Metabolic Solutions Development Co
1 investor across 1 round
See all investors in Metabolic Solutions Development Co
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 8, 2008
Amount
Undisclosed
Investors
Questions about Metabolic Solutions Development Co
Who invested in Metabolic Solutions Development Co?
Metabolic Solutions Development Co has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metabolic Solutions Development Co raised?
Metabolic Solutions Development Co has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Metabolic Solutions Development Co last raise money?
Metabolic Solutions Development Co's most recent round on record is a Series B, in Jan 2008.
What does Metabolic Solutions Development Co do?
Based in Michigan, US, and founded in 2006 by Chief Executive Officer Stephen Benoit, Metabolic Solutions Development Company LLC operates as a healthcare company providing insulin sensitizers, MSDC-0160 and MSDC-0602, mTOT modulators that lower glucose without the same degree of unwanted side effects such as fluid retention, weight gain, heart failure, edema, and bone loss.
Where is Metabolic Solutions Development Co headquartered?
Metabolic Solutions Development Co is headquartered in Kalamazoo, US.
Which VCs invest in companies like Metabolic Solutions Development Co?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Metabolic Solutions Development Co's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Metabolic Solutions Development Co? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.